Tremelimumab and Durvalumab in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery

NCT02754856 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Carcinoma in the Liver
Resectable Mass
Stage IV Colorectal Cancer AJCC v7
Stage IVA Colorectal Cancer AJCC v7
Stage IVB Colorectal Cancer AJCC v7

Interventions

BIOLOGICAL: Durvalumab
OTHER: Laboratory Biomarker Analysis
PROCEDURE: Therapeutic Conventional Surgery
BIOLOGICAL: Tremelimumab

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]